Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Pulmonary embolism is caused by a blocked artery in the lungs. The most common cause of such a blockage is a blood clot that forms in a deep vein in the leg and travels to the lungs, where it gets lodged in a smaller lung artery.
Almost all blood clots that cause pulmonary embolism are formed in the deep leg veins. Clots also can form in the deep veins of the arms or pelvis.
Sometimes blood clots form in surface veins. But these clots rarely lead to pulmonary embolism.
In rare cases, pulmonary embolism may be caused by other substances. They include:
Small masses of infectious material.
Fat. It can be released into the bloodstream after some types of bone fractures, surgery, trauma, or severe burns.
Air bubbles or substances that get into the blood from trauma, surgery, or medical procedures.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.